Neurofibromin pathway modulators
Patent Information
- Authority / Receiving Office
- US ยท United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- WASHINGTON UNIV IN SAINT LOUIS
- Publication Date
- 2009-08-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the priority of U.S. provisional application No. 60 / 987,156, filed Nov. 12, 2007, which is hereby incorporated by reference in its entirety.GOVERNMENTAL RIGHTS
[0002] This invention was made in part with Government support under Grant Number DAMD-17-03-1-0215 awarded by The Department of Defense and Grant Number U01-CA84314 awarded by the National Cancer Institute. The Government may have certain rights in this invention.FIELD OF THE INVENTION
[0003] The present invention relates to methods for treating neurofibromatosis and to methods for screening for modulators of the neurofibromin pathway.BACKGROUND OF THE INVENTION
[0004] NF1 is a common autosomal dominant disorder that affects approximately 1:3000 people worldwide (over 100,000 individuals in the United States alone) and predisposes to the development of both benign and malignant tumors, including optic glioma and malignant peripheral nerve sheath tumor (MPNST). Op...